A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients

Neuromuscular Disorders

Volumn 21, Issue 11, 2011, Pages 776-781

  Waddell, Leigh B ^a   Tran, Jenny ^a   Zheng, Xi F ^a   Bönnemann, Carsten G ^b   Hu, Ying ^b   Evesson, Frances J ^a   Lek, Monkol ^a   Arbuckle, Susan ^c   Wang, Min Xia ^a   Smith, Robert L ^d   North, Kathryn N ^a   Clarke, Nigel F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d JOHN HUNTER CHILDREN S HOSPITAL   (Australia)

Author keywords

BAG3; Diagnosis; FHL1; MATR3; Muscular dystrophy; PTRF; TCAP

Indexed keywords

ADENINE; CYSTEINE; GUANINE; TYROSINE;

ARTICLE; AUSTRALIAN; BCL ASSOCIATED ATHANOGENE 3 GENE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE COURSE; ETHNIC GROUP; FOUR AND A HALF LIM DOMAIN 1 GENE; GENE; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATR3 GENE; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; MYOPATHY; PATIENT ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PTRF GENE; TCAP GENE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AUSTRALIA; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIM DOMAIN PROTEINS; MALE; MUSCLE PROTEINS; MUSCULAR DYSTROPHIES; MUTATION; NUCLEAR MATRIX-ASSOCIATED PROTEINS; PHENOTYPE; RNA-BINDING PROTEINS;

EID: 82455167906     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2011.05.007     Document Type: Article

References (34)

1. Kaplan J.C. The 2011 version of the gene table of neuromuscular disorders. Neuromuscul Disord 2010, 20:852-873.
2. Bushby K.M. Making sense of the limb-girdle muscular dystrophies. Brain 1999, 122(Pt. 8):1403-1420.
3. Laval S.H., Bushby K.M. Limb-girdle muscular dystrophies - from genetics to molecular pathology. Neuropathol Appl Neurobiol 2004, 30:91-105.
4. Lo H.P., Cooper S.T., Evesson F.J., et al. Limb-girdle muscular dystrophy: diagnostic evaluation, frequency and clues to pathogenesis. Neuromuscul Disord 2008, 18:34-44.
5. Bushby K.M., Beckmann J.S. The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan limb-girdle muscular dystrophies, Naarden, April 12-14, 2002. Neuromuscul Disord 2003, 13:80-90.
6. Fanin M., Nascimbeni A.C., Aurino S., et al. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes. Neurology 2009, 72:1432-1435.
7. Norwood F.L., Harling C., Chinnery P.F., Eagle M., Bushby K., Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 2009, 132:3175-3186.
8. Peat R.A., Smith J.M., Compton A.G., et al. Diagnosis and aetiology of congenital muscular dystrophy. Neurology 2008, 71:312-321.
9. Schessl J., Zou Y., McGrath M.J., et al. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy. J Clin Invest 2008, 118:904-912.
10. Quinzii C.M., Vu T.H., Min K.C., et al. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. Am J Hum Genet 2008, 82:208-213.
11. Wilhelmsen K.C., Blake D.M., Lynch T., et al. Chromosome 12-linked autosomal dominant scapuloperoneal muscular dystrophy. Ann Neurol 1996, 39:507-520.
12. Windpassinger C., Schoser B., Straub V., et al. An X-linked myopathy with postural muscle atrophy and generalised hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008, 82:88-99.
13. Gueneau L., Bertrand A.T., Jais J.P., et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am J Hum Genet 2009, 85:338-353.
14. Selcen D., Muntoni F., Burton B.K., et al. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann Neurol 2009, 65:83-89.
15. Homma S., Iwasaki M., Shelton G.D., Engvall E., Reed J.C., Takayama S. BAG3 deficiency results in fulminant myopathy and early lethality. Am J Pathol 2006, 169:761-773.
16. Selcen D., Engel A.G. Mutations in myotilin cause myofibrillar myopathy. Neurology 2004, 62:1363-1371.
17. Feit H., Silbergleit A., Schneider L.B., et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localisation to 5q31. Am J Hum Genet 1998, 63:1732-1742.
18. Senderek J., Garvey S.M., Krieger M., et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 2009, 84:511-518.
19. 2+/calmodulin-binding protein cleaved by caspases. Biochem Biophys Res Commun 2007, 361:281-286.
20. Belgrader P., Dey R., Berezney R. Molecular cloning of matrin 3. A 125kilodalton protein of the nuclear matrix contains an extensive acidic domain. J Biol Chem 1991, 266:9893-9899.
21. Hayashi Y.K., Matsuda C., Ogawa M., et al. Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalised lipodystrophy. J Clin Invest 2009, 119:2623-2633.
22. Rajab A., Straub V., McCann L.J., et al. Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalised lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet 2010, 6:e1000874.
23. Moreira E.S., Wiltshire T.J., Faulkner G., et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet 2000, 24:163-166.
24. Olive M., Shatunov A., Gonzalez L., et al. Transcription-terminating mutation in telethonin causing autosomal recessive muscular dystrophy type 2G in a European patient. Neuromuscul Disord 2008, 18:929-933.
25. Moreira E.S., Vainzof M., Marie S.K., Sertie A.L., Zatz M., Passos-Bueno M.R. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet 1997, 61:151-159.
26. Valle G., Faulkner G., De Antoni A., et al. Telethonin, a novel sarcomeric protein of heart and skeletal muscle. FEBS Lett 1997, 415:163-168.
27. Zatz M., Vainzof M., Passos-Bueno M.R. Limb-girdle muscular dystrophy: one gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol 2000, 13:511-517.
28. Vainzof M., Moreira E.S., Suzuki O.T., et al. Telethonin protein expression in neuromuscular disorders. Biochim Biophys Acta 2002, 1588:33-40.
29. Zatz M., de Paula F., Starling A., Vainzof M. The 10 autosomal recessive limb-girdle muscular dystrophies. Neuromuscul Disord 2003, 13:532-544.
30. Price C. Australian population: ethnic origins. People and Place 1999, 7:12-16.
31. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
32. Durbin R.M., Abecasis G.R., Altshuler D.L., et al. A map of human genome variation from population-scale sequencing. Nature 2010, 467:1061-1073.
33. Cowling B.S., Cottle D.L., Wilding B.R., D'Arcy C.E., Mitchell C.A., McGrath M.J. Four and a half LIM protein 1 gene mutations cause four distinct human myopathies: a comprehensive review of the clinical, histological and pathological features. Neuromuscul Disord 2011, 21:237-251.
34. Shalaby S., Hayashi Y.K., Nonaka I., Noguchi S., Nishino I. Novel FHL1 mutations in fatal and benign reducing body myopathy. Neurology 2009, 72:375-376.